Pentasa and haemoglobin decreased Patient Reports February 12, 2012

Pentasa Side Effects Report #4653125-X
Pentasa side effect was reported by a Consumer or non-health professional from on Apr 19, 2005. Female patient, 67 years of age, weighting 168.0 lb, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood potassium decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, muscle spasms. Pentasa dosage: 1000 MG, 4X/DAY: QID, ORAL. During the same period patient was treated with ENTOCORT, BISOPROLOL W, CALCIUM, LASIX. Patient recovered.

Pentasa Side Effects Report #4660919-3
Pentasa side effect was reported by a Consumer or non-health professional from on May 05, 2005. Female patient, 67 years of age, weighting 168.0 lb, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood potassium decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, muscle spasms, musculoskeletal stiffness. Pentasa dosage: 1000 MG, 4X/DAY: QID,ORAL. During the same period patient was treated with ENTOCORT, BISOPROLOL W, CALCIUM, LASIX, SYNTHROID, PLE VITAMINS, VITAMIN B12, VITAMIN E. Patient recovered.

Pentasa Side Effects Report #5381284-2
Pentasa side effect was reported by a Physician from UNITED STATES on May 10, 2007. Male patient, 48 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: haemoglobin decreased, white blood cell count decreased. Pentasa dosage: 1000 MG 3X'S DAILY, ORAL. During the same period patient was treated with MERCAPTOPURINE, QUESTRAN. Patient recovered.

Pentasa Side Effects Report #5809994-0
Pentasa side effect was reported by a Physician from UNITED STATES on May 10, 2007. Male patient, 48 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, white blood cell count decreased. Pentasa dosage: 1000 MG 3X'S DAILY, ORAL. During the same period patient was treated with QUESTRAN. Patient recovered.


Pentasa Side Effects Report #4600461-9
Pentasa side effect was reported by a Health Professional from on Feb 18, 2005. Female patient, child 3 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria urine identified, cushingoid, escherichia infection, haematuria, haemoglobin decreased, laboratory test interference, nephritis. Pentasa dosage: 375 MG, DAILY, ORAL. During the same period patient was treated with METHYLPREDNISOLONE, SELENASE, ZINKAMIN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4614148-X
Pentasa side effect was reported by a Health Professional from on Mar 01, 2005. Male patient, 23 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: crohn's disease , disease recurrence, haemoglobin decreased, leukopenia, platelet count decreased. Pentasa dosage: 750 MG, 3X/DAY; TID, ORAL. During the same period patient was treated with MERCAPTOPURINE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4627936-0
Pentasa side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 23 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: haemoglobin decreased, leukopenia, platelet count decreased, proctalgia, pyrexia. Pentasa dosage: unknown. During the same period patient was treated with MERCAPTOPURINE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4634912-0
Pentasa side effect was reported by a Health Professional from on Mar 29, 2005. Male patient, 23 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: haemoglobin decreased, leukopenia, pancytopenia, proctalgia, thrombocytopenia. Pentasa dosage: unknown. During the same period patient was treated with MERCAPTOPURINE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5553696-5
Pentasa side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Male patient, 14 years of age, weighting 91.49 lb, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea haemorrhagic, dysphagia, eating disorder , emotional disorder, eye pain, haemoglobin decreased, lethargy. Pentasa dosage: 2000 MG, 2X/DAY:BID, ORAL. During the same period patient was treated with ASACOL, CANASA. Patient was hospitalized. Patient recovered.


Pentasa Side Effects Report #4827418-7
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2005. Female patient, 25 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cough, diarrhoea haemorrhagic, dyspnoea, eosinophil percentage increased, haemoglobin decreased, pleural effusion, pleurisy. Pentasa dosage: 2250 MG/DAY, ORAL. During the same period patient was treated with TIQUIZIUM BROMIDE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4928214-2
Pentasa side effect was reported by a Health Professional from JAPAN on Feb 10, 2006. Female patient, 25 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: antibody test abnormal, antinuclear antibody positive, chlamydial infection, clostridium colitis, diarrhoea haemorrhagic, eosinophil percentage increased, haemoglobin decreased, pleural effusion, pleurisy. Pentasa dosage: 2250 MG/DAY; ORAL. During the same period patient was treated with TIQUIZIUM BROMIDE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5189223-4
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Female patient, 23 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: chest pain , haemoglobin decreased, headache , heart rate increased, pleurisy, pneumonia , rhinorrhoea. Pentasa dosage: 500 MG 3XS DAILY; ORAL, 1000 MG 3XS DAILY,. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5908348-6
Pentasa side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Female patient, 29 years of age, weighting 160.9 lb, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, fatigue, haemoglobin decreased, nausea , off label use. Pentasa dosage: 4 X 500 MG TABLETS, 2X/DAY; BID; ORAL. During the same period patient was treated with MERCAPTOPURINE, PREDNISONE, CHLORDIAZEPOXIDE. Patient was hospitalized. Patient recovered.